Semarion Ltd
Semarion Ltd
Lonza and RION Join Forces for Exosome Breakthrough!
BIOT
🌟 Exciting collaboration! Lonza and RION are set to enhance exosome-based therapeutics manufacturing for innovative, affordable global treatments. 🌍💊🔬
EMA Revamps Drug Rules with AI and Innovation!
BIOT
🚀 The EMA's EMANS28 strategy updates drug regulation, enhancing medicine production and quality through continuous manufacturing and AI advancements! 🧪🤝
EMA-Gate: PharmaMar Triumphs Against Conflicts of Interest
BIOT
🔍 PharmaMar wins suit against EMA experts for conflicts of interest in non-authorization of Aplidin. 💊👨⚖️💰 EMAGate
EMA Approves 10 New Life-Changing Medicines!
BIOT
📢 EMA's CHMP recommended 10 medicines for approval in June 2024, including Balversa, Eurneffy, and mResvia. 💊👃💉
UK’s Semarion Ltd Wins Innovation Award for Revolutionary Lab Automation Platform
BIOT
🏆 Semarion Ltd. wins Ignite SME award for innovative lab automation at SLAS Europe 2024. 🧪✨ Faster drug development with Semacyte platform! 💡👩🔬🔬
